Once daily sublingual immunotherapy without updosing - A new treatment schedule

International Archives of Allergy and Immunology

Volumn 140, Issue 4, 2006, Pages 321-326

  Rodriguez, F ^a   Boquete, M ^b   Ibanez M D ^c   De La Torre Martinez F ^d   Tabar, A I ^e  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d ALK ABELLÓ   (Denmark)

^e Universidad Pública de Navarra   (Spain)

Author keywords

Allergy; Asthma; Immunotherapy; Rhinitis; Sublingual immunotherapy; Tolerability; Updosing

Indexed keywords

IMMUNOLOGIC AGENT; SLITONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEMALE; GRASS; HUMAN; IMMUNOTHERAPY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MITE; MULTICENTER STUDY; OCULAR PRURITUS; ORAL PRURITUS; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOCONJUNCTIVITIS; SCHOOL CHILD; SUBLINGUAL GLAND;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ANTIGENS, DERMATOPHAGOIDES; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOTHERAPY, ACTIVE; MALE; MIDDLE AGED; PLANT EXTRACTS; POACEAE; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 33746366468     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093710     Document Type: Article

References (8)

1. Wilson DR, Torres LM, Durham SR: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12.
2. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005;353:487-497.
3. Blaiss M: Current concepts and therapeutic strategies for allergic rhinitis in school-age children. Clin Ther 2004;26:1876-1889.
4. Bousquet J, Lockey RF, Malling HJ: WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53:1-42.
5. Pajno GB, Morabito L, Barberio G, Parmiani S: Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55:842-849.
6. Canonica GW, Passalacqua G: Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-448.
7. Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F: Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996;26:1253-1261.
8. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW: Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-1113.